Global and United States Influenza Vaccines Market Insights, Forecast to 2026

Publication ID:

QYR11201691

Publication Date:

November 23, 2020

Pages:

145

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Influenza Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Influenza Vaccines market is segmented into
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines

Segment by Application, the Influenza Vaccines market is segmented into
Adults
Pediatrics

Regional and Country-level Analysis
The Influenza Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Influenza Vaccines Market Share Analysis
Influenza Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Vaccines business, the date to enter into the Influenza Vaccines market, Influenza Vaccines product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra

Table Of Contents:

1 Study Coverage
1.1 Influenza Vaccines Product Introduction
1.2 Market Segments
1.3 Key Influenza Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type
1.4.2 Trivalent Flu Vaccines
1.4.3 Quadrivalent Flu Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccines Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Pediatrics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Influenza Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Influenza Vaccines Revenue 2015-2026
2.1.2 Global Influenza Vaccines Sales 2015-2026
2.2 Global Influenza Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Influenza Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Influenza Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Influenza Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Influenza Vaccines Revenue Forecast by Region (2021-2026)

3 Global Influenza Vaccines Competitor Landscape by Players
3.1 Global Top Influenza Vaccines Sales by Manufacturers
3.1.1 Global Influenza Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Influenza Vaccines Manufacturers by Revenue
3.2.1 Global Influenza Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Vaccines Revenue in 2019
3.2.5 Global Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Vaccines Price by Manufacturers
3.4 Global Influenza Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Influenza Vaccines Market Size by Type (2015-2020)
4.1.1 Global Influenza Vaccines Sales by Type (2015-2020)
4.1.2 Global Influenza Vaccines Revenue by Type (2015-2020)
4.1.3 Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Influenza Vaccines Market Size by Application (2015-2020)
5.1.1 Global Influenza Vaccines Sales by Application (2015-2020)
5.1.2 Global Influenza Vaccines Revenue by Application (2015-2020)
5.1.3 Influenza Vaccines Price by Application (2015-2020)
5.2 Influenza Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Vaccines Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Influenza Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Influenza Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Influenza Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Influenza Vaccines Market Share in Global Market 2015-2026
6.2 United States Influenza Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Influenza Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Influenza Vaccines Players by Revenue (2015-2020)
6.3 United States Influenza Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Influenza Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Influenza Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Influenza Vaccines Price by Type (2015-2020)
6.4 United States Influenza Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Influenza Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Influenza Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Influenza Vaccines Price Forecast by Type (2021-2026)
6.5 United States Influenza Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Influenza Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Influenza Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Influenza Vaccines Price by Application (2015-2020)
6.6 United States Influenza Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Influenza Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Influenza Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Influenza Vaccines Price Forecast by Application (2021-2026)

7 North America
7.1 North America Influenza Vaccines Market Size YoY Growth 2015-2026
7.2 North America Influenza Vaccines Market Facts & Figures by Country
7.2.1 North America Influenza Vaccines Sales by Country (2015-2020)
7.2.2 North America Influenza Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Influenza Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Influenza Vaccines Market Facts & Figures by Country
8.2.1 Europe Influenza Vaccines Sales by Country
8.2.2 Europe Influenza Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Influenza Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Influenza Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Influenza Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Influenza Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Influenza Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Influenza Vaccines Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccines Sales by Country
10.2.2 Latin America Influenza Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Influenza Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccines Sales by Country
11.2.2 Middle East and Africa Influenza Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Influenza Vaccines Products Offered
12.1.5 AstraZeneca Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Description and Business Overview
12.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Influenza Vaccines Products Offered
12.2.5 CSL Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Description and Business Overview
12.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Influenza Vaccines Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Influenza Vaccines Products Offered
12.4.5 Sanofi Recent Development
12.5 Altimmune
12.5.1 Altimmune Corporation Information
12.5.2 Altimmune Description and Business Overview
12.5.3 Altimmune Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Altimmune Influenza Vaccines Products Offered
12.5.5 Altimmune Recent Development
12.6 BionVax
12.6.1 BionVax Corporation Information
12.6.2 BionVax Description and Business Overview
12.6.3 BionVax Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BionVax Influenza Vaccines Products Offered
12.6.5 BionVax Recent Development
12.7 FluGen
12.7.1 FluGen Corporation Information
12.7.2 FluGen Description and Business Overview
12.7.3 FluGen Sales, Revenue and Gross Margin (2015-2020)
12.7.4 FluGen Influenza Vaccines Products Offered
12.7.5 FluGen Recent Development
12.8 FOLIA BIOTECH
12.8.1 FOLIA BIOTECH Corporation Information
12.8.2 FOLIA BIOTECH Description and Business Overview
12.8.3 FOLIA BIOTECH Sales, Revenue and Gross Margin (2015-2020)
12.8.4 FOLIA BIOTECH Influenza Vaccines Products Offered
12.8.5 FOLIA BIOTECH Recent Development
12.9 Genentech
12.9.1 Genentech Corporation Information
12.9.2 Genentech Description and Business Overview
12.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Genentech Influenza Vaccines Products Offered
12.9.5 Genentech Recent Development
12.10 Green Cross
12.10.1 Green Cross Corporation Information
12.10.2 Green Cross Description and Business Overview
12.10.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Green Cross Influenza Vaccines Products Offered
12.10.5 Green Cross Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Influenza Vaccines Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Moderna Therapeutics
12.12.1 Moderna Therapeutics Corporation Information
12.12.2 Moderna Therapeutics Description and Business Overview
12.12.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Moderna Therapeutics Products Offered
12.12.5 Moderna Therapeutics Recent Development
12.13 Novavax
12.13.1 Novavax Corporation Information
12.13.2 Novavax Description and Business Overview
12.13.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Novavax Products Offered
12.13.5 Novavax Recent Development
12.14 Shijiazhuang Yiling Pharmaceutical
12.14.1 Shijiazhuang Yiling Pharmaceutical Corporation Information
12.14.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
12.14.3 Shijiazhuang Yiling Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Shijiazhuang Yiling Pharmaceutical Products Offered
12.14.5 Shijiazhuang Yiling Pharmaceutical Recent Development
12.15 SK Chemicals
12.15.1 SK Chemicals Corporation Information
12.15.2 SK Chemicals Description and Business Overview
12.15.3 SK Chemicals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 SK Chemicals Products Offered
12.15.5 SK Chemicals Recent Development
12.16 UNM Pharma
12.16.1 UNM Pharma Corporation Information
12.16.2 UNM Pharma Description and Business Overview
12.16.3 UNM Pharma Sales, Revenue and Gross Margin (2015-2020)
12.16.4 UNM Pharma Products Offered
12.16.5 UNM Pharma Recent Development
12.17 Vaccitech
12.17.1 Vaccitech Corporation Information
12.17.2 Vaccitech Description and Business Overview
12.17.3 Vaccitech Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Vaccitech Products Offered
12.17.5 Vaccitech Recent Development
12.18 Vaxart
12.18.1 Vaxart Corporation Information
12.18.2 Vaxart Description and Business Overview
12.18.3 Vaxart Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Vaxart Products Offered
12.18.5 Vaxart Recent Development
12.19 Vaxine Pty
12.19.1 Vaxine Pty Corporation Information
12.19.2 Vaxine Pty Description and Business Overview
12.19.3 Vaxine Pty Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Vaxine Pty Products Offered
12.19.5 Vaxine Pty Recent Development
12.20 Visterra
12.20.1 Visterra Corporation Information
12.20.2 Visterra Description and Business Overview
12.20.3 Visterra Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Visterra Products Offered
12.20.5 Visterra Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Influenza Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.